Free shipping from €250 · Minimum order €150 — dispatched the next business day, tracked across the EU, with a lot-matched COA.

en

Glossary

Triple Agonist

Triple agonists activate the GLP-1, GIP and glucagon receptors with one molecule. The rationale for the glucagon arm and what published studies examined.

A triple agonist is one peptide engineered to stimulate three receptors at once. In metabolic research these are almost always the glucagon, GLP-1 and GIP receptors; the molecule is based on a proglucagon-family scaffold, protected by Aib residues and fitted with an albumin-binding lipid chain.

The reason for a third receptor

The two incretin components provide glucose-dependent insulin signalling and effects on appetite; the glucagon component contributes a reported rise in energy expenditure and hepatic lipid oxidation that neither incretin delivers. The engineering challenge is that glucagon receptor activation increases glucose output from the liver, so incretin potency has to be weighted strongly enough to counterbalance it. The real technical task is finding that balance, not the mere addition of a third receptor.

The best-known example

Retatrutide is the triple agonist studied most extensively, with human trial results published for the investigational medicine through phase 2 and on into phase 3. Such data describe the investigational drug within its specific trial protocols, not research-grade material with the same sequence.

See also incretin and dual agonist. Our comparison Retatrutide vs Tirzepatide adds detail, and the shop has a section for incretin-class peptides.

All glossary terms

Further reading

Guides that reference this term

Comparisons

Semaglutide vs Retatrutide: Single-Receptor Probe Against a Triple Agonist

Where a GLP-1 mono-agonist ends and a GIP/GLP-1/glucagon triple agonist begins — scaffold differences, the control arms each design needs, and what to verify before comparing them.

Comparisons

Retatrutide or Tirzepatide: One Extra Receptor and What It Costs in Attribution

Two peptides built on the same 39-residue scaffold, separated by a third receptor arm that changes both the biology and the controls a study needs.

Molecule guides

Retatrutide (LY3437943): Triple Receptor Design and What It Means for Study Design

Three receptor arms on one 39-residue backbone, in a fixed ratio no compound combination can copy. Also three reasons the data are harder to interpret.

Molecule guides

Obesity and Appetite Reagents: Which Families, Antisera and Kits to Order

A circuit, not a tissue: peripheral hunger and satiety signals, the hypothalamic neuropeptides they act on, and the adipokines — mapped to the reagents that study them.